Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Klaviyo, Inc.KVYO · Entity 3775 | Chief Legal Officer | August 28, 2026 | September 02, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Klaviyo, Inc.
Report date August 28, 2026 · Filed September 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Series A Common StockSEC Table I · non-derivative | Direct | 485,969 |
Reported balance
After 2026-08-28 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-08-28 · Sale · Disposed 53,473 · Balance 485,969 F1: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2025. F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.00 to $20.15 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| Series A Common StockSEC Table I · non-derivative | Direct | 477,866 |
Reported balance
After 2026-08-31 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2026-08-31 · Sale · Disposed 8,103 · Balance 477,866 F3: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 1, 2026. F4: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.95 to $20.77 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5: Consists of (i) 50,886 shares of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), (ii) 297,110 unvested restricted stock units awarded under the Issuer's 2023 Stock Option and Incentive Plan (the "Plan"), each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement, and (iii) 129,870 unvested performance stock units awarded under the Plan, each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement. |
Filing footnotes · ownership attribution and instrument terms
F1: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2025.
F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.00 to $20.15 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 1, 2026.
F4: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.95 to $20.77 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5: Consists of (i) 50,886 shares of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), (ii) 297,110 unvested restricted stock units awarded under the Issuer's 2023 Stock Option and Incentive Plan (the "Plan"), each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement, and (iii) 129,870 unvested performance stock units awarded under the Plan, each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 31, 2026 Filed Sep 2, 2026 00:16 UTC | Klaviyo, Inc. KVYO · Entity 3775 | SaleSeries A Common Stock | 8,103 | $20.44 | $165,625.32 |
DisclosureSEC source: 0001470831-26-000868 · wk-form4_1788308184.xml · nonDerivative · entry 2 Edmond Landon · CIK 0001991399 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 477,866 F3 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 1, 2026. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.95 to $20.77 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · balance_after: Consists of (i) 50,886 shares of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), (ii) 297,110 unvested restricted stock units awarded under the Issuer's 2023 Stock Option and Incentive Plan (the "Plan"), each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement, and (iii) 129,870 unvested performance stock units awarded under the Plan, each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement. Read SEC document |
| August 28, 2026 Filed Sep 2, 2026 00:16 UTC | Klaviyo, Inc. KVYO · Entity 3775 | SaleSeries A Common Stock | 53,473 | $20.01 | $1,069,994.73 |
DisclosureSEC source: 0001470831-26-000868 · wk-form4_1788308184.xml · nonDerivative · entry 1 Edmond Landon · CIK 0001991399 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 485,969 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2025. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.00 to $20.15 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 15, 2026 Filed Aug 19, 2026 00:06 UTC | Klaviyo, Inc. KVYO · Entity 3775 | Tax withholdingSeries A Common Stock | 22,342 | $18.49 | $413,103.58 |
DisclosureSEC source: 0001470831-26-000843 · wk-form4_1787098011.xml · nonDerivative · entry 1 Edmond Landon · CIK 0001991399 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 539,442 F1 · kind: Represents shares of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs"). F2 · balance_after: Consists of (i) 112,462 shares of Series A Common Stock; (ii) 297,110 unvested RSUs awarded under the Issuer's 2023 Stock Option and Incentive Plan (the "Plan"), each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement; and (iii) 129,870 unvested performance stock units awarded under the Plan, each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement. Read SEC document |
| May 15, 2026 Filed May 19, 2026 00:16 UTC | Klaviyo, Inc. KVYO · Entity 3775 | Tax withholdingSeries A Common Stock | 22,340 | $14.38 | $321,249.20 |
DisclosureSEC source: 0001470831-26-000461 · wk-form4_1779149764.xml · nonDerivative · entry 1 Edmond Landon · CIK 0001991399 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 561,784 F1 · kind: Represents shares of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs"). F2 · balance_after: Consists of (i) 93,396 shares of Series A Common Stock; (ii) 338,518 unvested RSUs awarded under the Issuer's 2023 Stock Option and Incentive Plan (the "Plan"), each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement; and (iii) 129,870 unvested performance stock units awarded under the Plan, each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement. Read SEC document |
| April 20, 2026 Filed Apr 23, 2026 00:01 UTC | Klaviyo, Inc. KVYO · Entity 3775 | SaleSeries A Common Stock | 9,623 | $20.00 | $192,460.00 |
DisclosureSEC source: 0001470831-26-000400 · wk-form4_1776902476.xml · nonDerivative · entry 1 Edmond Landon · CIK 0001991399 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 584,124 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2025. F2 · balance_after: Consists of (i) 74,332 shares of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), (ii) 379,922 unvested restricted stock units awarded under the Issuer's 2023 Stock Option and Incentive Plan (the "Plan"), each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement, and (iii) 129,870 unvested performance stock units awarded under the Plan, each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement. Read SEC document |
| April 15, 2026 Filed Apr 18, 2026 00:14 UTC | Klaviyo, Inc. KVYO · Entity 3775 | GrantSeries A Common Stock | 129,870 | $0.00 | $0.00 |
DisclosureSEC source: 0001470831-26-000384 · wk-form4_1776471278.xml · nonDerivative · entry 2 Edmond Landon · CIK 0001991399 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 593,747 F2 · shares: Represents performance stock units ("PSUs") awarded under the Plan, each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement. The PSUs will vest in up to three tranches over a two-year measurement period, subject to the achievement of specified performance targets tied to the trading price of the Series A Common Stock and the Reporting Person's continued service in the same or substantially equivalent position as the Reporting Person held as of the grant date through the applicable vesting date. Each tranche of PSUs will vest only if the average closing price of the Series A Common Stock for a period of at least sixty consecutive calendar days is at or above a specified dollar value during the applicable measurement period. F3 · shares: (continued) The stock price targets for tranches 1 through 3 are $30.00, $50.00, and $75.00 per share, respectively, subject to proportionate adjustment in the event of any stock split or other similar change in the Issuer's capital stock. F4 · balance_after: Consists of (i) 83,955 shares of Series A Common Stock; (ii) 379,922 unvested RSUs awarded under the Plan, each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement; and (iii) 129,870 unvested PSUs awarded under the Plan, each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement. Read SEC document |
| April 15, 2026 Filed Apr 18, 2026 00:14 UTC | Klaviyo, Inc. KVYO · Entity 3775 | GrantSeries A Common Stock | 151,515 | $0.00 | $0.00 |
DisclosureSEC source: 0001470831-26-000384 · wk-form4_1776471278.xml · nonDerivative · entry 1 Edmond Landon · CIK 0001991399 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 463,877 F1 · shares: Represents restricted stock units ("RSUs") awarded under the Issuer's 2023 Stock Option and Incentive Plan (the "Plan"), each representing the contingent right to receive one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), upon vesting and settlement. The RSUs vest as follows: (i) 50% of the RSUs will vest in eight equal quarterly installments, with the first such installment vesting on May 15, 2026, and (ii) thereafter the remaining 50% of the RSUs will vest in four equal quarterly installments, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| March 12, 2026 Filed Mar 13, 2026 23:58 UTC | Klaviyo, Inc. KVYO · Entity 3775 | SaleSeries A Common Stock | 14,366 | $20.15 | $289,474.90 |
DisclosureSEC source: 0001470831-26-000272 · wk-form4_1773446333.xml · nonDerivative · entry 1 Edmond Landon · CIK 0001991399 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 312,362 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2025. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.00 to $20.45 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Consists of (i) 83,955 shares of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and (ii) 228,407 unvested restricted stock units awarded under the Issuer's 2023 Stock Option and Incentive Plan, each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement. Read SEC document |
| March 05, 2026 Filed Mar 6, 2026 02:34 UTC | Klaviyo, Inc. KVYO · Entity 3775 | SaleSeries A Common Stock | 15,093 | $20.16 | $304,274.88 |
DisclosureSEC source: 0001470831-26-000249 · wk-form4_1772764470.xml · nonDerivative · entry 1 Edmond Landon · CIK 0001991399 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 326,728 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2025. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.00 to $20.63 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Consists of (i) 98,321 shares of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and (ii) 228,407 unvested restricted stock units awarded under the Issuer's 2023 Stock Option and Incentive Plan, each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement. Read SEC document |
| February 17, 2026 Filed Feb 18, 2026 21:16 UTC | Klaviyo, Inc. KVYO · Entity 3775 | ConversionSeries B Common Stock · Derivative | 11,052 | $0.00 | $0.00 |
DisclosureSEC source: 0001470831-26-000164 · wk-form4_1771449384.xml · derivative · entry 5 Edmond Landon · CIK 0001991399 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Series A Common Stock · 11,052 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F2 · derivative.exercise_date: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F2 · derivative.expiration_date: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. Read SEC document |
| February 17, 2026 Filed Feb 18, 2026 21:16 UTC | Klaviyo, Inc. KVYO · Entity 3775 | ConversionSeries A Common Stock | 11,052 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001470831-26-000164 · wk-form4_1771449384.xml · nonDerivative · entry 3 Edmond Landon · CIK 0001991399 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 341,821 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F4 · balance_after: Consists of (i) 113,414 shares of Series A Common Stock and (ii) 228,407 unvested RSUs awarded under the Issuer's 2023 Stock Option and Incentive Plan, each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement. Read SEC document |
| February 15, 2026 Filed Feb 18, 2026 21:16 UTC | Klaviyo, Inc. KVYO · Entity 3775 | ConversionSeries B Common Stock · Derivative | 11,448 | $0.00 | $0.00 |
DisclosureSEC source: 0001470831-26-000164 · wk-form4_1771449384.xml · derivative · entry 4 Edmond Landon · CIK 0001991399 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,052 Underlying: Series A Common Stock · 11,448 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F1 · kind: Represents 11,448 shares of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), automatically converted into shares of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), in connection with tax withholding obligations related to the vesting and settlement of restricted stock units ("RSUs"). F2 · derivative.exercise_date: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F2 · derivative.expiration_date: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. Read SEC document |
| February 15, 2026 Filed Feb 18, 2026 21:16 UTC | Klaviyo, Inc. KVYO · Entity 3775 | Tax withholdingSeries A Common Stock | 24,561 | $18.60 | $456,834.60 |
DisclosureSEC source: 0001470831-26-000164 · wk-form4_1771449384.xml · nonDerivative · entry 2 Edmond Landon · CIK 0001991399 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 330,769 F3 · kind: Represents shares of Series A Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs. Read SEC document |
| February 15, 2026 Filed Feb 18, 2026 21:16 UTC | Klaviyo, Inc. KVYO · Entity 3775 | ConversionSeries A Common Stock | 11,448 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001470831-26-000164 · wk-form4_1771449384.xml · nonDerivative · entry 1 Edmond Landon · CIK 0001991399 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 355,330 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents 11,448 shares of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), automatically converted into shares of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), in connection with tax withholding obligations related to the vesting and settlement of restricted stock units ("RSUs"). F2 · price: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. Read SEC document |
| January 15, 2026 Filed Jan 16, 2026 21:04 UTC | Klaviyo, Inc. KVYO · Entity 3775 | SaleSeries A Common Stock | 4,399 | $25.52 | $112,262.48 |
DisclosureSEC source: 0001470831-26-000039 · wk-form4_1768597468.xml · nonDerivative · entry 2 Edmond Landon · CIK 0001991399 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 343,882 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2025. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.36 to $25.68 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · balance_after: Consists of (i) 90,284 shares of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and (ii) 253,598 unvested restricted stock units awarded under the Issuer's 2023 Stock Option and Incentive Plan, each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement. Read SEC document |
| January 15, 2026 Filed Jan 16, 2026 21:04 UTC | Klaviyo, Inc. KVYO · Entity 3775 | SaleSeries A Common Stock | 5,601 | $26.08 | $146,074.08 |
DisclosureSEC source: 0001470831-26-000039 · wk-form4_1768597468.xml · nonDerivative · entry 1 Edmond Landon · CIK 0001991399 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 348,281 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2025. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.80 to $26.73 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 18, 2025 Filed Dec 19, 2025 21:08 UTC | Klaviyo, Inc. KVYO · Entity 3775 | SaleSeries A Common Stock | 472 | $30.55 | $14,419.60 |
DisclosureSEC source: 0001470831-25-000447 · wk-form4_1766178477.xml · nonDerivative · entry 2 Edmond Landon · CIK 0001991399 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 353,882 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2025. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.45 to $30.63 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · balance_after: Consists of (i) 100,284 shares of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and (ii) 253,598 unvested restricted stock units awarded under the Issuer's 2023 Stock Option and Incentive Plan, each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement. Read SEC document |
| December 18, 2025 Filed Dec 19, 2025 21:08 UTC | Klaviyo, Inc. KVYO · Entity 3775 | SaleSeries A Common Stock | 13,718 | $31.41 | $430,882.38 |
DisclosureSEC source: 0001470831-25-000447 · wk-form4_1766178477.xml · nonDerivative · entry 1 Edmond Landon · CIK 0001991399 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 354,354 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2025. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.64 to $31.63 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 22:22 UTC | Klaviyo, Inc. KVYO · Entity 3775 | GiftSeries A Common Stock | 8,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001470831-25-000429 · wk-form4_1766010150.xml · nonDerivative · entry 1 Edmond Landon · CIK 0001991399 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 368,072 F1 · kind: Represents a bona fide gift of 8,400 shares of stock from the Reporting Person to a donor-advised fund. F2 · balance_after: Consists of (i) 114,474 shares of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and (ii) 253,598 unvested restricted stock units awarded under the Issuer's 2023 Stock Option and Incentive Plan, each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement. Read SEC document |
| November 20, 2025 Filed Nov 21, 2025 21:08 UTC | Klaviyo, Inc. KVYO · Entity 3775 | SaleSeries A Common Stock | 4,020 | $26.97 | $108,419.40 |
DisclosureSEC source: 0001470831-25-000361 · wk-form4_1763759281.xml · nonDerivative · entry 2 Edmond Landon · CIK 0001991399 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 376,472 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2025. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.84 to $27.34 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · balance_after: Consists of (i) 122,874 shares of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and (ii) 253,598 unvested restricted stock units awarded under the Issuer's 2023 Stock Option and Incentive Plan, each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement. Read SEC document |
| November 20, 2025 Filed Nov 21, 2025 21:08 UTC | Klaviyo, Inc. KVYO · Entity 3775 | SaleSeries A Common Stock | 10,374 | $27.83 | $288,708.42 |
DisclosureSEC source: 0001470831-25-000361 · wk-form4_1763759281.xml · nonDerivative · entry 1 Edmond Landon · CIK 0001991399 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 380,492 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2025. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.45 to $28.39 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 17, 2025 Filed Nov 18, 2025 21:10 UTC | Klaviyo, Inc. KVYO · Entity 3775 | ConversionSeries B Common Stock · Derivative | 11,074 | $0.00 | $0.00 |
DisclosureSEC source: 0001470831-25-000337 · wk-form4_1763500254.xml · derivative · entry 5 Edmond Landon · CIK 0001991399 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,500 Underlying: Series A Common Stock · 11,074 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F2 · derivative.exercise_date: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F2 · derivative.expiration_date: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F5 · balance_after: Consists of 22,500 unvested RSUs awarded under the Issuer's 2015 Stock Incentive Plan, each representing the contingent right to receive one share of Series B Common Stock upon vesting and settlement. Read SEC document |
| November 17, 2025 Filed Nov 18, 2025 21:10 UTC | Klaviyo, Inc. KVYO · Entity 3775 | ConversionSeries A Common Stock | 11,074 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001470831-25-000337 · wk-form4_1763500254.xml · nonDerivative · entry 3 Edmond Landon · CIK 0001991399 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 390,866 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F4 · balance_after: Consists of (i) 137,268 shares of Series A Common Stock and (ii) 253,598 unvested RSUs awarded under the Issuer's 2023 Stock Option and Incentive Plan, each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement. Read SEC document |
| November 15, 2025 Filed Nov 18, 2025 21:10 UTC | Klaviyo, Inc. KVYO · Entity 3775 | ConversionSeries B Common Stock · Derivative | 11,426 | $0.00 | $0.00 |
DisclosureSEC source: 0001470831-25-000337 · wk-form4_1763500254.xml · derivative · entry 4 Edmond Landon · CIK 0001991399 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,574 Underlying: Series A Common Stock · 11,426 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F1 · kind: Represents 11,426 shares of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), automatically converted into shares of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), in connection with tax withholding obligations related to the vesting and settlement of restricted stock units ("RSUs"). F2 · derivative.exercise_date: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F2 · derivative.expiration_date: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. Read SEC document |
| November 15, 2025 Filed Nov 18, 2025 21:10 UTC | Klaviyo, Inc. KVYO · Entity 3775 | Tax withholdingSeries A Common Stock | 24,218 | $28.61 | $692,876.98 |
DisclosureSEC source: 0001470831-25-000337 · wk-form4_1763500254.xml · nonDerivative · entry 2 Edmond Landon · CIK 0001991399 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 379,792 F3 · kind: Represents shares of Series A Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs. Read SEC document |
| November 15, 2025 Filed Nov 18, 2025 21:10 UTC | Klaviyo, Inc. KVYO · Entity 3775 | ConversionSeries A Common Stock | 11,426 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001470831-25-000337 · wk-form4_1763500254.xml · nonDerivative · entry 1 Edmond Landon · CIK 0001991399 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 404,010 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents 11,426 shares of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), automatically converted into shares of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), in connection with tax withholding obligations related to the vesting and settlement of restricted stock units ("RSUs"). F2 · price: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. Read SEC document |
| August 18, 2025 Filed Aug 20, 2025 00:44 UTC | Klaviyo, Inc. KVYO · Entity 3775 | ConversionSeries B Common Stock · Derivative | 11,074 | $0.00 | $0.00 |
DisclosureSEC source: 0001470831-25-000139 · wk-form4_1755650660.xml · derivative · entry 6 Edmond Landon · CIK 0001991399 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 45,000 Underlying: Series A Common Stock · 11,074 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F2 · derivative.exercise_date: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F2 · derivative.expiration_date: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F7 · balance_after: Consists of 45,000 unvested RSUs awarded under the Issuer's 2015 Stock Incentive Plan, each representing the contingent right to receive one share of Series B Common Stock upon vesting and settlement. Read SEC document |
| August 18, 2025 Filed Aug 20, 2025 00:44 UTC | Klaviyo, Inc. KVYO · Entity 3775 | SaleSeries A Common Stock | 9,965 | $31.46 | $313,498.90 |
DisclosureSEC source: 0001470831-25-000139 · wk-form4_1755650660.xml · nonDerivative · entry 4 Edmond Landon · CIK 0001991399 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 392,584 F4 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.20 to $31.76 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F6 · balance_after: Consists of (i) 113,798 shares of Series A Common Stock and (ii) 278,786 unvested RSUs awarded under the Issuer's 2023 Stock Option and Incentive Plan, each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement. Read SEC document |
| August 18, 2025 Filed Aug 20, 2025 00:44 UTC | Klaviyo, Inc. KVYO · Entity 3775 | ConversionSeries A Common Stock | 11,074 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001470831-25-000139 · wk-form4_1755650660.xml · nonDerivative · entry 3 Edmond Landon · CIK 0001991399 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 402,549 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. Read SEC document |
| August 15, 2025 Filed Aug 20, 2025 00:44 UTC | Klaviyo, Inc. KVYO · Entity 3775 | ConversionSeries B Common Stock · Derivative | 11,426 | $0.00 | $0.00 |
DisclosureSEC source: 0001470831-25-000139 · wk-form4_1755650660.xml · derivative · entry 5 Edmond Landon · CIK 0001991399 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 56,074 Underlying: Series A Common Stock · 11,426 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F1 · kind: Represents 11,426 shares of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), automatically converted into shares of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), in connection with tax withholding obligations related to the vesting and settlement of restricted stock units ("RSUs"). F2 · derivative.exercise_date: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F2 · derivative.expiration_date: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. Read SEC document |
| August 15, 2025 Filed Aug 20, 2025 00:44 UTC | Klaviyo, Inc. KVYO · Entity 3775 | Tax withholdingSeries A Common Stock | 24,695 | $31.43 | $776,163.85 |
DisclosureSEC source: 0001470831-25-000139 · wk-form4_1755650660.xml · nonDerivative · entry 2 Edmond Landon · CIK 0001991399 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 391,475 F3 · kind: Represents shares of Series A Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs. Read SEC document |
| August 15, 2025 Filed Aug 20, 2025 00:44 UTC | Klaviyo, Inc. KVYO · Entity 3775 | ConversionSeries A Common Stock | 11,426 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001470831-25-000139 · wk-form4_1755650660.xml · nonDerivative · entry 1 Edmond Landon · CIK 0001991399 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 416,170 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents 11,426 shares of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), automatically converted into shares of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), in connection with tax withholding obligations related to the vesting and settlement of restricted stock units ("RSUs"). F2 · price: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. Read SEC document |
| May 16, 2025 Filed May 17, 2025 00:47 UTC | Klaviyo, Inc. KVYO · Entity 3775 | SaleSeries A Common Stock | 9,965 | $34.85 | $347,280.25 |
DisclosureSEC source: 0001835830-25-000058 · wk-form4_1747442865.xml · nonDerivative · entry 4 Edmond Landon · CIK 0001991399 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 404,744 F4 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $34.50 to $35.37 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F6 · balance_after: Consists of (i) 99,831 shares of Series A Common Stock and (ii) 304,913 unvested RSUs awarded under the Issuer's 2023 Stock Option and Incentive Plan, each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement. Read SEC document |
| May 15, 2025 Filed May 17, 2025 00:47 UTC | Klaviyo, Inc. KVYO · Entity 3775 | ConversionSeries B Common Stock · Derivative | 11,074 | $0.00 | $0.00 |
DisclosureSEC source: 0001835830-25-000058 · wk-form4_1747442865.xml · derivative · entry 6 Edmond Landon · CIK 0001991399 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 67,500 Underlying: Series A Common Stock · 11,074 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F2 · derivative.exercise_date: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F2 · derivative.expiration_date: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F7 · balance_after: Consists of 67,500 unvested RSUs awarded under the Issuer's 2015 Stock Incentive Plan, each representing the contingent right to receive one share of Series B Common Stock upon vesting and settlement. Read SEC document |
| May 15, 2025 Filed May 17, 2025 00:47 UTC | Klaviyo, Inc. KVYO · Entity 3775 | ConversionSeries B Common Stock · Derivative | 11,426 | $0.00 | $0.00 |
DisclosureSEC source: 0001835830-25-000058 · wk-form4_1747442865.xml · derivative · entry 5 Edmond Landon · CIK 0001991399 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 78,574 Underlying: Series A Common Stock · 11,426 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F1 · kind: Represents 11,426 shares of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), automatically converted into shares of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), in connection with tax withholding obligations related to the vesting and settlement of restricted stock units ("RSUs"). F2 · derivative.exercise_date: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F2 · derivative.expiration_date: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. Read SEC document |
| May 15, 2025 Filed May 17, 2025 00:47 UTC | Klaviyo, Inc. KVYO · Entity 3775 | ConversionSeries A Common Stock | 11,074 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001835830-25-000058 · wk-form4_1747442865.xml · nonDerivative · entry 3 Edmond Landon · CIK 0001991399 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 414,709 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. Read SEC document |
| May 15, 2025 Filed May 17, 2025 00:47 UTC | Klaviyo, Inc. KVYO · Entity 3775 | Tax withholdingSeries A Common Stock | 24,694 | $34.90 | $861,820.60 |
DisclosureSEC source: 0001835830-25-000058 · wk-form4_1747442865.xml · nonDerivative · entry 2 Edmond Landon · CIK 0001991399 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 403,635 F3 · kind: Represents shares of Series A Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs. Read SEC document |
| May 15, 2025 Filed May 17, 2025 00:47 UTC | Klaviyo, Inc. KVYO · Entity 3775 | ConversionSeries A Common Stock | 11,426 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001835830-25-000058 · wk-form4_1747442865.xml · nonDerivative · entry 1 Edmond Landon · CIK 0001991399 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 428,329 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents 11,426 shares of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), automatically converted into shares of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), in connection with tax withholding obligations related to the vesting and settlement of restricted stock units ("RSUs"). F2 · price: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. Read SEC document |
| March 17, 2025 Filed Mar 18, 2025 22:50 UTC | Klaviyo, Inc. KVYO · Entity 3775 | GrantSeries A Common Stock | 130,072 | $0.00 | $0.00 |
DisclosureSEC source: 0001835830-25-000029 · wk-form4_1742338198.xml · nonDerivative · entry 1 Edmond Landon · CIK 0001991399 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 416,903 F1 · shares: Represents restricted stock units ("RSUs") awarded under the Issuer's 2023 Stock Option and Incentive Plan, each representing the contingent right to receive one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), upon vesting and settlement. The RSUs vest as follows: (i) 50% of the RSUs will vest in eight equal quarterly installments, with the first such installment vesting on May 15, 2025, and (ii) thereafter the remaining 50% of the RSUs will vest in four equal quarterly installments, subject to the Reporting Person's continued service on each such vesting date. F2 · balance_after: Consists of (i) 85,864 shares of Series A Common Stock and (ii) 331,039 unvested RSUs awarded under the Issuer's 2023 Stock Option and Incentive Plan, each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 21:14 UTC | Klaviyo, Inc. KVYO · Entity 3775 | SaleSeries A Common Stock | 2,322 | $38.20 | $88,700.40 |
DisclosureSEC source: 0001835830-25-000025 · wk-form4_1741209276.xml · nonDerivative · entry 2 Edmond Landon · CIK 0001991399 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 286,831 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.05 to $38.37 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · balance_after: Consists of (i) 85,864 shares of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and (ii) 200,967 unvested restricted stock units awarded under the Issuer's 2023 Stock Option and Incentive Plan, each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 21:14 UTC | Klaviyo, Inc. KVYO · Entity 3775 | SaleSeries A Common Stock | 3,900 | $39.26 | $153,114.00 |
DisclosureSEC source: 0001835830-25-000025 · wk-form4_1741209276.xml · nonDerivative · entry 1 Edmond Landon · CIK 0001991399 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 289,153 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.94 to $39.64 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 22:43 UTC | Klaviyo, Inc. KVYO · Entity 3775 | ConversionSeries B Common Stock · Derivative | 3,586 | $0.00 | $0.00 |
DisclosureSEC source: 0001835830-25-000018 · wk-form4_1740004987.xml · derivative · entry 5 Edmond Landon · CIK 0001991399 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,000 Underlying: Series A Common Stock · 3,586 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into shares of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F2 · derivative.exercise_date: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into shares of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F2 · derivative.expiration_date: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into shares of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F5 · balance_after: Consists of 90,000 unvested RSUs awarded under the Issuer's 2015 Stock Incentive Plan, each representing the contingent right to receive one share of Series B Common Stock upon vesting and settlement. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 22:43 UTC | Klaviyo, Inc. KVYO · Entity 3775 | ConversionSeries B Common Stock · Derivative | 3,914 | $0.00 | $0.00 |
DisclosureSEC source: 0001835830-25-000018 · wk-form4_1740004987.xml · derivative · entry 4 Edmond Landon · CIK 0001991399 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,586 Underlying: Series A Common Stock · 3,914 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into shares of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F1 · kind: Represents 3,914 shares of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), automatically converted into shares of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), in connection with tax withholding obligations related to the vesting and settlement of restricted stock units ("RSUs"). F2 · derivative.exercise_date: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into shares of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F2 · derivative.expiration_date: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into shares of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 22:43 UTC | Klaviyo, Inc. KVYO · Entity 3775 | ConversionSeries A Common Stock | 3,586 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001835830-25-000018 · wk-form4_1740004987.xml · nonDerivative · entry 3 Edmond Landon · CIK 0001991399 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 293,053 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into shares of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F4 · balance_after: Consists of (i) 92,086 shares of Series A Common Stock and (ii) 200,967 unvested RSUs awarded under the Issuer's 2023 Stock Option and Incentive Plan, each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 22:43 UTC | Klaviyo, Inc. KVYO · Entity 3775 | Tax withholdingSeries A Common Stock | 13,054 | $47.00 | $613,538.00 |
DisclosureSEC source: 0001835830-25-000018 · wk-form4_1740004987.xml · nonDerivative · entry 2 Edmond Landon · CIK 0001991399 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 289,467 F3 · kind: Represents shares of Series A Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 22:43 UTC | Klaviyo, Inc. KVYO · Entity 3775 | ConversionSeries A Common Stock | 3,914 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001835830-25-000018 · wk-form4_1740004987.xml · nonDerivative · entry 1 Edmond Landon · CIK 0001991399 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 302,521 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents 3,914 shares of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), automatically converted into shares of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), in connection with tax withholding obligations related to the vesting and settlement of restricted stock units ("RSUs"). F2 · price: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into shares of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. Read SEC document |
| January 07, 2025 Filed Jan 11, 2025 00:02 UTC | Klaviyo, Inc. KVYO · Entity 3775 | SaleSeries A Common Stock | 25,207 | $41.62 | $1,049,115.34 |
DisclosureSEC source: 0001835830-25-000003 · wk-form4_1736553714.xml · nonDerivative · entry 2 Edmond Landon · CIK 0001991399 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 298,607 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.22 to $41.89 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · balance_after: Consists of (i) 79,642 shares of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and (ii) 218,965 unvested restricted stock units awarded under the Issuer's 2023 Stock Option and Incentive Plan, each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement. Read SEC document |
| January 07, 2025 Filed Jan 11, 2025 00:02 UTC | Klaviyo, Inc. KVYO · Entity 3775 | SaleSeries A Common Stock | 14,793 | $42.10 | $622,785.30 |
DisclosureSEC source: 0001835830-25-000003 · wk-form4_1736553714.xml · nonDerivative · entry 1 Edmond Landon · CIK 0001991399 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 323,814 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.90 to $42.89 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 21:36 UTC | Klaviyo, Inc. KVYO · Entity 3775 | ConversionSeries B Common Stock · Derivative | 101,986 | $0.00 | $0.00 |
DisclosureSEC source: 0001835830-24-000121 · wk-form4_1734557773.xml · derivative · entry 2 Edmond Landon · CIK 0001991399 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97,500 Underlying: Series A Common Stock · 101,986 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into shares of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F1 · derivative.exercise_date: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into shares of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F1 · derivative.expiration_date: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into shares of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F3 · balance_after: Consists of 97,500 unvested RSUs awarded under the Issuer's 2015 Stock Incentive Plan, each representing the contingent right to receive one share of the Issuer's Series B Common Stock upon vesting and settlement. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 21:36 UTC | Klaviyo, Inc. KVYO · Entity 3775 | ConversionSeries A Common Stock | 101,986 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001835830-24-000121 · wk-form4_1734557773.xml · nonDerivative · entry 1 Edmond Landon · CIK 0001991399 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 338,607 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into shares of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F2 · balance_after: Consists of (i) 119,642 shares of Series A Common Stock and (ii) 218,965 unvested restricted stock units ("RSUs") awarded under the Issuer's 2023 Stock Option and Incentive Plan, each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.